Corporate ActionMay 11, 2026, 05:12 PM
Picard Medical Raises $5.0M in Public Offering
AI Summary
Picard Medical, Inc. completed a registered public offering, raising approximately $5.0 million in gross proceeds. The offering included common stock or pre-funded warrants, along with Series A and Series B warrants, with proceeds intended for working capital, general corporate purposes, and debt repayment. Concurrently, the company received a notice from NYSE American indicating non-compliance with continued listing standards due to stockholders' equity falling below $4.0 million, requiring a plan to regain compliance by November 2027.
Key Highlights
- Picard Medical raised approximately $5.0 million in gross proceeds from a registered public offering.
- The offering included 16,666,667 shares or pre-funded warrants, plus Series A and Series B warrants.
- The combined public offering price was $0.30 per share/warrant combo or $0.2999 per pre-funded warrant/warrant combo.
- Common Warrants are exercisable at $0.35 per share, and Pre-Funded Warrants at $0.0001 per share.
- The company received a NYSE American notice for non-compliance with the $4.0 million stockholders' equity rule, reporting $3.8 million.
- Picard Medical must submit a plan by June 7, 2026, to regain NYSE American compliance by November 8, 2027.
- WestPark Capital, Inc. received a 7.0% cash fee, and a financial advisor received a 1.0% management fee.
- The company agreed to a 60-day lock-up on common stock issuance and a 90-day lock-up on variable rate transactions.